SG185746A1 - Treatment of autoimmune diseases - Google Patents

Treatment of autoimmune diseases Download PDF

Info

Publication number
SG185746A1
SG185746A1 SG2012086526A SG2012086526A SG185746A1 SG 185746 A1 SG185746 A1 SG 185746A1 SG 2012086526 A SG2012086526 A SG 2012086526A SG 2012086526 A SG2012086526 A SG 2012086526A SG 185746 A1 SG185746 A1 SG 185746A1
Authority
SG
Singapore
Prior art keywords
halogen
compound
formula
phenyl
prodrug
Prior art date
Application number
SG2012086526A
Other languages
English (en)
Inventor
Peter Gergely
Erik Wallstroem
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42199281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG185746(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG185746A1 publication Critical patent/SG185746A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG2012086526A 2010-05-06 2011-05-05 Treatment of autoimmune diseases SG185746A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10162079 2010-05-06
PCT/EP2011/057203 WO2011138393A1 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
SG185746A1 true SG185746A1 (en) 2013-01-30

Family

ID=42199281

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012086526A SG185746A1 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Country Status (24)

Country Link
US (1) US20130172297A1 (https=)
EP (1) EP2566470A1 (https=)
JP (1) JP2013530937A (https=)
KR (1) KR20130066630A (https=)
CN (1) CN102869353A (https=)
AU (1) AU2011249784B2 (https=)
BR (1) BR112012028190A2 (https=)
CA (1) CA2795394A1 (https=)
CL (1) CL2012003091A1 (https=)
CR (1) CR20120566A (https=)
CU (1) CU20120154A7 (https=)
EA (1) EA201201514A1 (https=)
EC (1) ECSP12012312A (https=)
IL (1) IL222690A0 (https=)
MA (1) MA34285B1 (https=)
MX (1) MX2012012926A (https=)
NZ (1) NZ603999A (https=)
PE (1) PE20130612A1 (https=)
PH (1) PH12012502418A1 (https=)
SG (1) SG185746A1 (https=)
TN (1) TN2012000509A1 (https=)
TW (1) TW201201814A (https=)
WO (1) WO2011138393A1 (https=)
ZA (1) ZA201207710B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519539B (zh) * 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
US9289494B2 (en) * 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2461212C (en) 2001-09-27 2010-08-17 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
DE60235900D1 (de) * 2001-09-27 2010-05-20 Kyorin Seiyaku Kk Osuppressivum
JP4571497B2 (ja) * 2002-09-19 2010-10-27 杏林製薬株式会社 アミノアルコール誘導体とその付加塩及び免疫抑制剤
BRPI0407658A (pt) * 2003-02-18 2006-02-21 Kyorin Seiyaku Kk derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
EP1628957B1 (en) * 2003-05-26 2010-09-29 Takeda Pharmaceutical Company Limited Sulfopyrroles
ATE449069T1 (de) 2003-08-28 2009-12-15 Novartis Pharma Gmbh Aminopropanolderivate
CA2553704C (en) * 2004-02-11 2011-04-19 Basilea Pharmaceutica Ag Substituted benzimidazoles and their use for inducing apoptosis
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
ES2529724T3 (es) * 2005-09-09 2015-02-25 Novartis Ag Tratamiento de enfermedades autoinmunes

Also Published As

Publication number Publication date
WO2011138393A1 (en) 2011-11-10
EP2566470A1 (en) 2013-03-13
ECSP12012312A (es) 2012-12-28
CA2795394A1 (en) 2011-11-10
CU20120154A7 (es) 2013-03-27
TW201201814A (en) 2012-01-16
NZ603999A (en) 2014-06-27
CR20120566A (es) 2013-01-09
JP2013530937A (ja) 2013-08-01
IL222690A0 (en) 2012-12-31
ZA201207710B (en) 2013-06-26
MA34285B1 (fr) 2013-06-01
PE20130612A1 (es) 2013-06-06
EA201201514A1 (ru) 2013-05-30
MX2012012926A (es) 2012-12-17
KR20130066630A (ko) 2013-06-20
AU2011249784A1 (en) 2012-12-20
PH12012502418A1 (en) 2018-03-21
US20130172297A1 (en) 2013-07-04
AU2011249784B2 (en) 2014-03-06
CL2012003091A1 (es) 2013-03-22
TN2012000509A1 (en) 2014-04-01
CN102869353A (zh) 2013-01-09
BR112012028190A2 (pt) 2016-08-02

Similar Documents

Publication Publication Date Title
US7825260B2 (en) Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
US8008286B2 (en) Method for treatment of neuropathic pain
TWI592391B (zh) 用於合成及使用造影劑之組合物、方法及系統
AU2010224355B2 (en) Treatment of autoimmune diseases
PT1140078E (pt) Agentes de benzimidazole para problemas de vascularização
KR20070104407A (ko) 아미노기 및 페닐기로 치환된 5원 헤테로사이클 및시클로알칸을 포함하는 스핑고신 1-포스페이트 효능제
US20080076739A1 (en) Methods for treating arthritis using triheterocyclic compounds
EP2139889B1 (en) Amino-naphthyridine derivatives
JP2023182589A (ja) フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
US8450318B2 (en) Method to treat infections using anti-infective agents
US11135209B2 (en) Compositions and methods for inhibiting protein kinases
SG185746A1 (en) Treatment of autoimmune diseases
BR112017000605B1 (pt) Forma policristalina do pró-fármaco de tenofovir, seu método de preparação e seu uso, e composição farmacêutica
US20180161290A1 (en) Dosage Regimen of Diaryl Sulfide Derivatives
FI60711C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5,5-dimetyl-8-(p-fluorfenylalkyl)-10-hydroxi-2-(2-propynyl)-1,2,3,4-tetrahydro-5h-bensopyrano (4,3-c) pyridiner
US20260034115A1 (en) Yap1 inhibitors
WO2010099573A1 (en) Dioxolane norbornane / norbornene compounds suitable as antimicrobial agents to treat bacterial infections
CN121627598A (zh) 一种嘧啶-2-苯胺衍生物及其合成方法和应用
HK40030015A (en) Compositions, methods and systems for the synthesis and use of imaging agents